Cargando…

Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus

BACKGROUND: Deep brain stimulation (DBS) has become a preferred option for the treatment of motor symptoms in patients with advanced Parkinson’s disease (PD). A good levodopa response (LR) is considered the most important criterion in determining the suitability of a patient for DBS. However, the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Aygun, Dursun, Kocabicak, Ersoy, Yildiz, Mustafa Onur, Temel, Yasin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921481/
https://www.ncbi.nlm.nih.gov/pubmed/27445964
http://dx.doi.org/10.3389/fneur.2016.00097
_version_ 1782439505935990784
author Aygun, Dursun
Kocabicak, Ersoy
Yildiz, Mustafa Onur
Temel, Yasin
author_facet Aygun, Dursun
Kocabicak, Ersoy
Yildiz, Mustafa Onur
Temel, Yasin
author_sort Aygun, Dursun
collection PubMed
description BACKGROUND: Deep brain stimulation (DBS) has become a preferred option for the treatment of motor symptoms in patients with advanced Parkinson’s disease (PD). A good levodopa response (LR) is considered the most important criterion in determining the suitability of a patient for DBS. However, the effect of age and disease duration (DD) on the LR is still a subject of discussion. OBJECTIVE: Here, we investigated the effect of age and DD on the preoperative LR in PD patients to be selected for DBS. METHODS: From August 2011 to May 2015, 54 consecutive patients (29 men and 25 women) with advanced PD were evaluated for DBS of the STN and included in this retrospective study. RESULTS: Thirty-seven patients were found suitable for DBS of the STN and 29 of them underwent bilateral surgery. We found no significant correlation between DD and the LR. However, there was a significant negative correlation between the patients’ age and the LR. CONCLUSION: The results indicate that the patients’ age, rather than DD, has a negative effect on the LR. The study, therefore, indicates that PD patients with an advanced age and with a poor LR are not good candidates for DBS of the STN.
format Online
Article
Text
id pubmed-4921481
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-49214812016-07-21 Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus Aygun, Dursun Kocabicak, Ersoy Yildiz, Mustafa Onur Temel, Yasin Front Neurol Neuroscience BACKGROUND: Deep brain stimulation (DBS) has become a preferred option for the treatment of motor symptoms in patients with advanced Parkinson’s disease (PD). A good levodopa response (LR) is considered the most important criterion in determining the suitability of a patient for DBS. However, the effect of age and disease duration (DD) on the LR is still a subject of discussion. OBJECTIVE: Here, we investigated the effect of age and DD on the preoperative LR in PD patients to be selected for DBS. METHODS: From August 2011 to May 2015, 54 consecutive patients (29 men and 25 women) with advanced PD were evaluated for DBS of the STN and included in this retrospective study. RESULTS: Thirty-seven patients were found suitable for DBS of the STN and 29 of them underwent bilateral surgery. We found no significant correlation between DD and the LR. However, there was a significant negative correlation between the patients’ age and the LR. CONCLUSION: The results indicate that the patients’ age, rather than DD, has a negative effect on the LR. The study, therefore, indicates that PD patients with an advanced age and with a poor LR are not good candidates for DBS of the STN. Frontiers Media S.A. 2016-06-27 /pmc/articles/PMC4921481/ /pubmed/27445964 http://dx.doi.org/10.3389/fneur.2016.00097 Text en Copyright © 2016 Aygun, Kocabicak, Yildiz and Temel. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Aygun, Dursun
Kocabicak, Ersoy
Yildiz, Mustafa Onur
Temel, Yasin
Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus
title Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus
title_full Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus
title_fullStr Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus
title_full_unstemmed Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus
title_short Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus
title_sort effect of age and disease duration on the levodopa response in patients with advanced parkinson’s disease for deep brain stimulation of the subthalamic nucleus
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921481/
https://www.ncbi.nlm.nih.gov/pubmed/27445964
http://dx.doi.org/10.3389/fneur.2016.00097
work_keys_str_mv AT aygundursun effectofageanddiseasedurationonthelevodoparesponseinpatientswithadvancedparkinsonsdiseasefordeepbrainstimulationofthesubthalamicnucleus
AT kocabicakersoy effectofageanddiseasedurationonthelevodoparesponseinpatientswithadvancedparkinsonsdiseasefordeepbrainstimulationofthesubthalamicnucleus
AT yildizmustafaonur effectofageanddiseasedurationonthelevodoparesponseinpatientswithadvancedparkinsonsdiseasefordeepbrainstimulationofthesubthalamicnucleus
AT temelyasin effectofageanddiseasedurationonthelevodoparesponseinpatientswithadvancedparkinsonsdiseasefordeepbrainstimulationofthesubthalamicnucleus